Clinical Trials Directory

Trials / Unknown

UnknownNCT02026323

The Effect of Acupuncture on Insulin Sensitivity Polycystic Ovary Syndrome

Effect of Acupuncture on Insulin Sensitivity in Women With Polycystic Ovary Syndrome and Insulin Resistance: Study Protocol of a Prospective Observational Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
112 (estimated)
Sponsor
The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
Sex
Female
Age
18 Years – 49 Years
Healthy volunteers
Not accepted

Summary

Hyperinsulinemia and insulin resistance play a key role in the pathogenesis of polycystic ovary syndrome (PCOS). Insulin resistance is significantly associated with the long-term risks of metabolic syndrome and cardiovascular disease. Acupuncture with electrical stimulation has in rats with dihydrotestosterone (DHT)-induced PCOS been shown to improve insulin sensitivity. Whether these findings can be translated into women with PCOS has not been investigated. Therefore, this study aims to evaluate whether acupuncture improves insulin sensitivity, ovulation rate and quality of life in women with PCOS. Our hypothesis is that acupuncture with combined manual and low-frequency electrical stimulation of the needles improves insulin resistance, induces ovulation and improves quality of life.

Detailed description

This is a prospective observational study. A total of 112 women with PCOS and insulin resistance will be recruited and randomized into two groups according to their body mass index (BMI), i.e. normal weight (BMI=18.5-23Kg/m2) group and overweight or obese (BMI \> 23Kg/m2) group1. The acupuncture treatment will last for six months, 3 times per week, 30 minutes per treatment. The primary outcome is changes in insulin sensitivity from baseline to after 6 months of acupuncture treatment measured by OGTT.

Conditions

Interventions

TypeNameDescription
OTHERacupunctureacupuncture

Timeline

Start date
2014-01-01
Primary completion
2014-10-01
Completion
2015-05-01
First posted
2014-01-01
Last updated
2014-09-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02026323. Inclusion in this directory is not an endorsement.